血脂异常的科学计量研究

Rekha Phull, V. Deshpande, Gaurav Phull
{"title":"血脂异常的科学计量研究","authors":"Rekha Phull, V. Deshpande, Gaurav Phull","doi":"10.9734/JPRI/2021/V33I32A31713","DOIUrl":null,"url":null,"abstract":"Dyslipidaemia an ever increasing menace emerging out of present lifestyle, is one of the major risk factors for developing Cardio-vascular abnormalities like Coronary Artery Disease (CAD), Myocardial infarction (MI), Cardiac arrest and is often associated with other metabolic disorders. Clinicians across the globe are trying hard to combat it. We have presented a Scientometric analysis of dyslipidaemia which includes Ayurvedic perspective also. Objective: In this study we intended to study detailed Scientometric and Bibliometric study on dyslipidaemia literature. Materials and methods: The data was collected using databases of Sciencedirect and Scopus, using the keywords ‘Dyslipidaemia’, ‘Dyslipidaemia in Ayurveda’, ‘Dyslipidaemia in India’,‘Medoroga in Ayurveda’ and ‘Medoraga in India’. Review Article Phull et al.; JPRI, 33(32A): 27-37, 2021; Article no.JPRI.69687 28 Results: A total of 85,500 items were retrieved from ‘science direct’ website, where majority of them were research articles and maximum publications were from the last decade indicating the recent enhancement in prevalence and awareness. A volley of research papers have come up with multiple approaches which include modern pharmacological measures, Ayurveda remedies and other herbal medicines along with non-pharmacological approaches like Yoga and Pranayama. Newer therapeutic agents like Ezetimibe, proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies, PCSK9 small interference RNA (siRNA), and bempedoic acid, when added to the commonly used statin therapy have shown additional improvement to CV outcomes. Recent advances have come up with hepatocyte-specific targeting modifications and have shown promising lipid lowering effects. Conclusion: Our study was probably the first such kind of work in field of dyslipidaemia which includes publications related to Ayurveda and other herbal remedies also. It shows the ever rising trends in the publications related to dyslipidaemia and its relation to other metabolic disorders in recent years. The major concern is the progression in cases of dyslipidaemia and its cardiovascular outcomes despite of having substantial research work and awareness in different streams of medicine. We must focus on the multifactorial approach encouraging behavioural, dietary and pharmacological control of cholesterol and sensitize the masses about its serious consequences. A cumulative approach including modern advances with much safer herbal remedies and practice of Yogasana and Pranayama is the need of hour and may probably bring the best solution.","PeriodicalId":16706,"journal":{"name":"Journal of Pharmaceutical Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Scientometric Study on Dyslipidaemia\",\"authors\":\"Rekha Phull, V. Deshpande, Gaurav Phull\",\"doi\":\"10.9734/JPRI/2021/V33I32A31713\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dyslipidaemia an ever increasing menace emerging out of present lifestyle, is one of the major risk factors for developing Cardio-vascular abnormalities like Coronary Artery Disease (CAD), Myocardial infarction (MI), Cardiac arrest and is often associated with other metabolic disorders. Clinicians across the globe are trying hard to combat it. We have presented a Scientometric analysis of dyslipidaemia which includes Ayurvedic perspective also. Objective: In this study we intended to study detailed Scientometric and Bibliometric study on dyslipidaemia literature. Materials and methods: The data was collected using databases of Sciencedirect and Scopus, using the keywords ‘Dyslipidaemia’, ‘Dyslipidaemia in Ayurveda’, ‘Dyslipidaemia in India’,‘Medoroga in Ayurveda’ and ‘Medoraga in India’. Review Article Phull et al.; JPRI, 33(32A): 27-37, 2021; Article no.JPRI.69687 28 Results: A total of 85,500 items were retrieved from ‘science direct’ website, where majority of them were research articles and maximum publications were from the last decade indicating the recent enhancement in prevalence and awareness. A volley of research papers have come up with multiple approaches which include modern pharmacological measures, Ayurveda remedies and other herbal medicines along with non-pharmacological approaches like Yoga and Pranayama. Newer therapeutic agents like Ezetimibe, proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies, PCSK9 small interference RNA (siRNA), and bempedoic acid, when added to the commonly used statin therapy have shown additional improvement to CV outcomes. Recent advances have come up with hepatocyte-specific targeting modifications and have shown promising lipid lowering effects. Conclusion: Our study was probably the first such kind of work in field of dyslipidaemia which includes publications related to Ayurveda and other herbal remedies also. It shows the ever rising trends in the publications related to dyslipidaemia and its relation to other metabolic disorders in recent years. The major concern is the progression in cases of dyslipidaemia and its cardiovascular outcomes despite of having substantial research work and awareness in different streams of medicine. We must focus on the multifactorial approach encouraging behavioural, dietary and pharmacological control of cholesterol and sensitize the masses about its serious consequences. A cumulative approach including modern advances with much safer herbal remedies and practice of Yogasana and Pranayama is the need of hour and may probably bring the best solution.\",\"PeriodicalId\":16706,\"journal\":{\"name\":\"Journal of Pharmaceutical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.9734/JPRI/2021/V33I32A31713\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.9734/JPRI/2021/V33I32A31713","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

血脂异常是当前生活方式中出现的一种日益严重的威胁,是发生冠状动脉疾病(CAD)、心肌梗死(MI)、心脏骤停等心血管异常的主要风险因素之一,通常与其他代谢紊乱有关。全球各地的临床医生都在努力对抗它。我们对血脂异常进行了科学分析,其中也包括阿育吠陀的观点。目的:本研究旨在对血脂异常文献进行详细的科学计量和文献计量研究。材料和方法:使用Sciencedirect和Scopus的数据库收集数据,关键词为“血脂异常”、“阿育吠陀中的血脂异常”,“印度的血脂异常,阿育吠达中的Medoroga”和“印度的Medoraga”。评论文章Phull等人。;JPRI,33(32A):2021年27月37日;文章编号:JPRI.69687 28结果:从“科学直接”网站上共检索到85500个项目,其中大多数是研究文章,最多的出版物来自过去十年,表明最近的流行率和意识有所提高。一系列研究论文提出了多种方法,包括现代药理学措施、阿育吠陀疗法和其他草药,以及瑜伽和Pranayama等非药理学方法。在常用的他汀类药物治疗中加入新的治疗剂,如依替米贝、前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9)单克隆抗体、PCSK9小干扰RNA(siRNA)和贝米多酸,已显示出对CV结果的额外改善。最近的进展已经提出了肝细胞特异性靶向修饰,并显示出有希望的降脂效果。结论:我们的研究可能是血脂异常领域的第一项此类工作,其中包括与阿育吠陀和其他草药相关的出版物。它显示了近年来与血脂异常及其与其他代谢紊乱的关系有关的出版物的不断上升的趋势。主要关注的是血脂异常病例的进展及其心血管后果,尽管在不同的医学领域有大量的研究工作和认识。我们必须把重点放在鼓励胆固醇的行为、饮食和药理学控制的多因素方法上,并让群众意识到其严重后果。一种累积的方法,包括更安全的草药疗法的现代进步,以及瑜伽和普拉纳山的练习,是需要时间的,可能会带来最好的解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Scientometric Study on Dyslipidaemia
Dyslipidaemia an ever increasing menace emerging out of present lifestyle, is one of the major risk factors for developing Cardio-vascular abnormalities like Coronary Artery Disease (CAD), Myocardial infarction (MI), Cardiac arrest and is often associated with other metabolic disorders. Clinicians across the globe are trying hard to combat it. We have presented a Scientometric analysis of dyslipidaemia which includes Ayurvedic perspective also. Objective: In this study we intended to study detailed Scientometric and Bibliometric study on dyslipidaemia literature. Materials and methods: The data was collected using databases of Sciencedirect and Scopus, using the keywords ‘Dyslipidaemia’, ‘Dyslipidaemia in Ayurveda’, ‘Dyslipidaemia in India’,‘Medoroga in Ayurveda’ and ‘Medoraga in India’. Review Article Phull et al.; JPRI, 33(32A): 27-37, 2021; Article no.JPRI.69687 28 Results: A total of 85,500 items were retrieved from ‘science direct’ website, where majority of them were research articles and maximum publications were from the last decade indicating the recent enhancement in prevalence and awareness. A volley of research papers have come up with multiple approaches which include modern pharmacological measures, Ayurveda remedies and other herbal medicines along with non-pharmacological approaches like Yoga and Pranayama. Newer therapeutic agents like Ezetimibe, proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies, PCSK9 small interference RNA (siRNA), and bempedoic acid, when added to the commonly used statin therapy have shown additional improvement to CV outcomes. Recent advances have come up with hepatocyte-specific targeting modifications and have shown promising lipid lowering effects. Conclusion: Our study was probably the first such kind of work in field of dyslipidaemia which includes publications related to Ayurveda and other herbal remedies also. It shows the ever rising trends in the publications related to dyslipidaemia and its relation to other metabolic disorders in recent years. The major concern is the progression in cases of dyslipidaemia and its cardiovascular outcomes despite of having substantial research work and awareness in different streams of medicine. We must focus on the multifactorial approach encouraging behavioural, dietary and pharmacological control of cholesterol and sensitize the masses about its serious consequences. A cumulative approach including modern advances with much safer herbal remedies and practice of Yogasana and Pranayama is the need of hour and may probably bring the best solution.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
4 weeks
期刊最新文献
Ayurvedic Management of Hypothyroidism - A Case Report Clinical Study and Assessment of Efficacy of Polyherbal Combination (KNDBHU) in COVID 19 Patients A Study on Prognostic Factors in Management of Breast Carcinoma in A Tertiary Care Hospital Simultaneous Determination of 11 Commonly used Cephalosporin Antibiotics Residue by High Performance Liquid Chromatography - Diode Array Detectors in Pharmaceutical Waste Water - A Tool for Controlling One of the Source of Antibiotic Resistance Virgin Coconut Oil Solubilised Curcumin Protects Nephropathy in Diabetic Rats
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1